News in brief: Children with neurological conditions eligible for Pfizer vaccine; Stem cell hydrogel: a new tool against Parkinson’s disease?; Senior doctors quarantined because kids’ school has COVID-19 case

ATAGI recommends Pfizer vaccine for children with neurological conditions Children aged 12–15 with neurological conditions are among the high risk groups for COVID-19 that should prioritised for vaccination using the Comirnaty (Pfizer) vaccine, according to the Australian Technical Advisory Group on Immunisation (ATAGI) Following the recent TGA approval of Pfizer vaccine to be extended from ...

Already a member?

Login to keep reading.

© 2021 the limbic